$379 Million is the total value of Ghost Tree Capital, LLC's 43 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 51.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | Sell | SPDR SER TRput | $33,585,000 | -41.2% | 300,000 | -59.3% | 8.86% | -41.5% |
| IMMU | Sell | IMMUNOMEDICS INC | $20,378,000 | +44.0% | 575,000 | -45.2% | 5.38% | +43.2% |
| SPY | Sell | SPDR S&P 500 ETF TRput | $20,043,000 | -47.0% | 65,000 | -55.7% | 5.29% | -47.3% |
| CNST | CONSTELLATION PHARMCETICLS I | $19,533,000 | -4.4% | 650,000 | 0.0% | 5.15% | -4.9% | |
| ADVM | Sell | ADVERUM BIOTECHNOLOGIES INC | $18,792,000 | +47.3% | 900,000 | -31.1% | 4.96% | +46.6% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $17,696,000 | +100.2% | 155,000 | +34.8% | 4.67% | +99.1% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $15,921,000 | +52.0% | 580,000 | +65.7% | 4.20% | +51.2% |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $14,625,000 | +25.4% | 625,000 | -68.8% | 3.86% | +24.8% |
| RCKT | ROCKET PHARMACEUTICALS INC | $13,605,000 | +50.0% | 650,000 | 0.0% | 3.59% | +49.2% | |
| MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $12,809,000 | +17.7% | 385,000 | -3.8% | 3.38% | +17.1% |
| IMVT | Sell | IMMUNOVANT INC | $12,784,000 | +15.7% | 525,000 | -26.1% | 3.37% | +15.1% |
| QQQ | Sell | INVESCO QQQ TRput | $12,364,000 | -62.7% | 50,000 | -71.3% | 3.26% | -62.9% |
| Buy | TRILLIUM THERAPEUTICS INC | $12,337,000 | +270.1% | 1,525,000 | +84.8% | 3.26% | +268.2% | |
| TGTX | Buy | TG THERAPEUTICS INC | $11,688,000 | +493.9% | 600,000 | +200.0% | 3.08% | +490.8% |
| STSA | Buy | SATSUMA PHARMACEUTICALS INC | $9,778,000 | +295.1% | 340,000 | +195.7% | 2.58% | +293.3% |
| GILD | New | GILEAD SCIENCES INCcall | $9,618,000 | – | 125,000 | +100.0% | 2.54% | – |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $9,614,000 | -43.1% | 65,000 | -56.7% | 2.54% | -43.4% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $9,054,000 | +126.4% | 1,900,000 | -5.0% | 2.39% | +125.2% |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $8,938,000 | +54.0% | 550,000 | +37.5% | 2.36% | +53.2% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $8,228,000 | -34.9% | 100,000 | -53.5% | 2.17% | -35.3% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $7,998,000 | – | 165,000 | +100.0% | 2.11% | – |
| RETA | REATA PHARMACEUTICALS INCcl a | $7,801,000 | +8.1% | 50,000 | 0.0% | 2.06% | +7.5% | |
| AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $6,666,000 | +139.9% | 825,000 | +135.7% | 1.76% | +138.7% |
| MYOV | Sell | MYOVANT SCIENCES LTD | $6,186,000 | +40.0% | 300,000 | -48.7% | 1.63% | +39.2% |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $6,150,000 | – | 115,000 | +100.0% | 1.62% | – |
| WVE | New | WAVE LIFE SCIENCES LTD | $5,569,000 | – | 535,000 | +100.0% | 1.47% | – |
| SURF | New | SURFACE ONCOLOGY INC | $4,592,000 | – | 700,000 | +100.0% | 1.21% | – |
| ISEE | Buy | IVERIC BIO INC | $4,590,000 | +61.1% | 900,000 | +8.6% | 1.21% | +60.2% |
| FATE | Sell | FATE THERAPEUTICS INC | $4,289,000 | -14.2% | 125,000 | -44.4% | 1.13% | -14.6% |
| KALV | KALVISTA PHARMACEUTICALS INC | $4,235,000 | +58.1% | 350,000 | 0.0% | 1.12% | +57.3% | |
| ALDX | New | ALDEYRA THERAPEUTICS INC | $4,170,000 | – | 1,000,000 | +100.0% | 1.10% | – |
| XENE | XENON PHARMACEUTICALS INC | $4,076,000 | +10.6% | 325,000 | 0.0% | 1.08% | +9.9% | |
| ARVN | Buy | ARVINAS INC | $4,025,000 | +24.8% | 120,000 | +50.0% | 1.06% | +24.2% |
| FIXX | Buy | HOMOLOGY MEDICINES INC | $3,570,000 | +14.9% | 235,000 | +17.5% | 0.94% | +14.3% |
| SELB | Sell | SELECTA BIOSCIENCES INC | $2,840,000 | -31.7% | 1,000,000 | -42.0% | 0.75% | -32.1% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $2,742,000 | -0.0% | 185,000 | -26.0% | 0.72% | -0.7% |
| GILD | New | GILEAD SCIENCES INC | $1,924,000 | – | 25,000 | +100.0% | 0.51% | – |
| PYPD | New | POLYPID LTD | $1,803,000 | – | 100,000 | +100.0% | 0.48% | – |
| ALT | New | ALTIMMUNE INC | $1,607,000 | – | 150,000 | +100.0% | 0.42% | – |
| KNSA | Sell | KINIKSA PHARMACEUTICALS LTD | $1,274,000 | -27.0% | 50,000 | -55.6% | 0.34% | -27.4% |
| VRAY | Sell | VIEWRAY INC | $672,000 | -65.7% | 300,000 | -61.7% | 0.18% | -65.9% |
| MRNA | New | MODERNA INC | $642,000 | – | 10,000 | +100.0% | 0.17% | – |
| FXE | Sell | INVESCO CURRENCYSHARES EURO | $212,000 | -90.2% | 2,000 | -90.4% | 0.06% | -90.3% |
| MIST | Exit | MILESTONE PHARMACEUTICALS IN | $0 | – | -208,733 | -100.0% | -0.10% | – |
| AMRN | Exit | AMARIN CORP PLCcall | $0 | – | -165,600 | -100.0% | -0.18% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -3,250 | -100.0% | -0.27% | – |
| AGTC | Exit | APPLIED GENETIC TECHNOL CORP | $0 | – | -372,806 | -100.0% | -0.32% | – |
| ORTX | Exit | ORCHARD THERAPEUTICS PLCads | $0 | – | -178,109 | -100.0% | -0.36% | – |
| KDMN | Exit | KADMON HLDGS INC | $0 | – | -350,000 | -100.0% | -0.39% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -227,827 | -100.0% | -0.43% | – |
| PHAS | Exit | PHASEBIO PHARMACEUTICALS INC | $0 | – | -497,074 | -100.0% | -0.44% | – |
| CUE | Exit | CUE BIOPHARMA INC | $0 | – | -125,000 | -100.0% | -0.47% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -65,000 | -100.0% | -0.50% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -150,000 | -100.0% | -0.64% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -150,000 | -100.0% | -0.98% | – |
| VSTM | Exit | VERASTEM INC | $0 | – | -1,500,000 | -100.0% | -1.05% | – |
| XLV | Exit | SELECT SECTOR SPDR TRcall | $0 | – | -244,700 | -100.0% | -5.75% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.